Researchers found that classical (CL) and mesenchymal (MES) glioblastoma (GBM) stem cells were enriched in reactive immune region and high CL-MES signature informed poor prognosis in GBM.
[Nature Communications]
Home Newsletters Cancer Stem Cell News Combined Targeting of Glioblastoma Stem Cells of Different Cellular States Disrupts Malignant...
